Treatment of Early COVID-19

Outpatient Treatment Options Now Available

Treatment of COVID-19 continues to evolve. Treatments are now available for early COVID that may reduce the risk of complications and even death.

If you have coronavirus infection/COVID-19 illness, Affinia Healthcare wants to help. Call us at 314-814-8700 as soon as possible to be connected with a clinician for possible early treatment that may prevent severe illness. Medicaid, Gateway to Better Health coverage, Medicare, and most commercial insurance plans are accepted. Sliding fees are offered for uninsured persons who qualify.

Monoclonal Antibody Infusion Therapy and Oral Antiviral Therapy

If you have tested positive for COVID-19, please ask your medical provider if you are a good candidate for these therapies, which include sotrovimab (infusion), Paxlovid (oral) or molnupiravir (oral). These treatments are prescribed for patients who have mild to moderate symptoms of COVID-19 and an elevated risk of complications. Data from clinical trials showed that high-risk patients treated with these therapies had up to 88% reduction in relative risk of progression to severe disease or hospitalization compared to patients who did not receive these therapies. Please discuss with your provider to find out if you are eligible.
*You will need a referral from your medical provider for these services.*

Affinia Healthcare offers these services at no out-of-pocket cost to patients. For questions about these therapies and the referral process, please call 314-449-3553.

These treatments are provided across from Affinia Healthcare’s location at 4414 N. Florissant at:

The Urban League Peter Bunce Campus at 2125 Bissell Street, 63107.